G. Blessman

Learn More
A drug utilization observation study collected data on a total of 1800 patients given flavoxate (Spasuret® 200) over 2 weeks for urge incontinence. Efficacy and tolerance parameters were determined. A subgroup of 618 patients without urinary tract infections or benign prostatic hyperplasia were treated with flavoxate only. The subgroup (n= 618) showed a(More)
  • 1